HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,884 | -5.8% | 310 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $33,833 | +430.9% | 310 | +453.6% | 0.01% | +400.0% |
| Q4 2022 | $6,373 | -83.2% | 56 | -90.9% | 0.00% | -85.7% |
| Q3 2022 | $38,000 | +90.0% | 617 | +144.8% | 0.01% | +133.3% |
| Q2 2022 | $20,000 | -16.7% | 252 | +11.5% | 0.00% | -25.0% |
| Q1 2022 | $24,000 | +300.0% | 226 | +303.6% | 0.00% | +300.0% |
| Q4 2021 | $6,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -80.6% | 56 | -83.3% | 0.00% | -87.5% |
| Q2 2021 | $31,000 | +158.3% | 335 | +148.1% | 0.01% | +166.7% |
| Q1 2021 | $12,000 | -14.3% | 135 | -29.3% | 0.00% | -25.0% |
| Q4 2020 | $14,000 | -6.7% | 191 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $15,000 | +87.5% | 191 | +41.5% | 0.01% | +66.7% |
| Q2 2020 | $8,000 | +100.0% | 135 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |